Groundbreaking Human Clinical Research Study Finds Ripple THC Products Are Absorbed 2x Faster Than Market-Leading THC Gummies

CANNANNEW REPORT

Study is the cannabis industry’s first published “real world” human clinical research using state-legal THC products DENVER–(BUSINESS WIRE)–Ripple, a leading brand of cannabis edibles, is advancing scientific understanding of how “real world” cannabis products work. The findings of a recent independent human clinical study on THC edibles help to add transparency to the cannabis industry for the benefit of consumers. The study, conducted independently by Colorado State University researchers and published in the peer-reviewed, open-access scientific journal Pharmaceuticals, explored the pharmacokinetics of edible THC. It also found that all Ripple products were absorbed into the bloodstream significantly faster than market-leading gummy products, including those marketed as “quick.” The differences were seen across the board, from Ripple Gummies (2.3X faster than the leading gummy), Ripple Dissolvables (1.9X faster) and Ripple QuickSticks (1.5X faster). While other THC edibles brands claim on their labels that they’re fast-acting or quick-absorbing, no company has actually substantiated such a claim using the actual products available for sale, until now. This study represents the first human clinical substantiation of a ‘fast-acting’ claim in consumer cannabis edibles, and validates Ripple’s commitment to backing all its products and claims with rigorous science. “Our commitment to substantiation and honesty makes us an outlier in an industry full of hyperbole and outright lies,” said Justin Singer, Ripple CEO and Co-Founder. “Companies like to throw around terms like ‘water-soluble’ or ‘nano,’ but they’re just meaningless buzzwords without actual scientific proof. We believe in truth in advertising even when no one is enforcing it, so we invested in the research to prove—both to consumers and to ourselves—that our products do what we say they do.” Importantly, the findings represent the first published human clinical research study of commercially available THC products. “The FDA keeps asking for ‘real world evidence’ on consumer cannabinoid products.…

Excerpt only …
READ MORE BELOW
Source : Groundbreaking Human Clinical Research Study Finds Ripple THC Products Are Absorbed 2x Faster Than Market-Leading THC Gummies

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.